Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary M Horowitz

Showing results (171-180 of 260) with videos related to

Pageof 26
Sort By:
Transplantation and Cellular Therapy|October 6, 2022
Corrigendum to 'Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation' [Biology of Blood and Marrow Transplantation 26/10 (2020) 1876-1885]Saurabh Chhabra, Alexis Visotcky, Marcelo C Pasquini, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2012
Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant ResearchMarcelo C Pasquini, Julio Voltarelli, Harold L Atkins, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 13, 2020
Ixazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell TransplantationSaurabh Chhabra, Alexis Visotcky, Marcelo C Pasquini, et al.
Bone Marrow Transplantation|October 17, 2019
Correction: Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countriesIbrahim N Muhsen, Shahrukh K Hashmi, Dietger Niederwieser, et al.
Blood|November 4, 2015
The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancyCraig Kollman, Stephen R Spellman, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 27, 2015
Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated DonorsJo-Anne H Young, Brent R Logan, Juan Wu, et al.
The Lancet. Oncology|October 4, 2011
Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trialAmrita Krishnan, Marcelo C Pasquini, Brent Logan, et al.
The Lancet. Haematology|July 30, 2022
Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trialAmy E DeZern, Mary Eapen, Juan Wu, et al.
Blood|August 30, 2014
Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802Javier Bolaños-Meade, Brent R Logan, Amin M Alousi, et al.
Bone Marrow Transplantation|September 6, 2019
Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countriesIbrahim N Muhsen, Shahrukh K Hashmi, Dietger Niederwieser, et al.
Pageof 26

Showing results (171-180 of 260) with videos related to

Sort By:
Pageof 26
Transplantation and Cellular Therapy|October 6, 2022
Corrigendum to 'Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation' [Biology of Blood and Marrow Transplantation 26/10 (2020) 1876-1885]Saurabh Chhabra, Alexis Visotcky, Marcelo C Pasquini, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2012
Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant ResearchMarcelo C Pasquini, Julio Voltarelli, Harold L Atkins, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 13, 2020
Ixazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell TransplantationSaurabh Chhabra, Alexis Visotcky, Marcelo C Pasquini, et al.
Bone Marrow Transplantation|October 17, 2019
Correction: Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countriesIbrahim N Muhsen, Shahrukh K Hashmi, Dietger Niederwieser, et al.
Blood|November 4, 2015
The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancyCraig Kollman, Stephen R Spellman, Mei-Jie Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 27, 2015
Infections after Transplantation of Bone Marrow or Peripheral Blood Stem Cells from Unrelated DonorsJo-Anne H Young, Brent R Logan, Juan Wu, et al.
The Lancet. Oncology|October 4, 2011
Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trialAmrita Krishnan, Marcelo C Pasquini, Brent Logan, et al.
The Lancet. Haematology|July 30, 2022
Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trialAmy E DeZern, Mary Eapen, Juan Wu, et al.
Blood|August 30, 2014
Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802Javier Bolaños-Meade, Brent R Logan, Amin M Alousi, et al.
Bone Marrow Transplantation|September 6, 2019
Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countriesIbrahim N Muhsen, Shahrukh K Hashmi, Dietger Niederwieser, et al.
Pageof 26